Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Gastro Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Gastro Other
    Endoscopic Ultrasound-Fine Needle Aspiration Predicts 5-year Survival in Pancreatic Endocrine Tumours - (DGNews)
    Study Finds Prevalence of Barrett's Oesophagus in Asymptomatic Women - (DGNews)
    Benefits of Bariatric Surgery in Adolescents Persist After 2 Years: Presented at AHA - (DGDispatch)
    Lubiprostone Approved in Switzerland for Chronic Idiopathic Constipation - (DGNews)
    FDA: Avoid Coadministration of Clopidogrel and Omeprazole, Esomeprazole - (DGNews)

    News archive

     Recent webcasts/CME - Gastro Other
  • Applying Evidence to Improve Outcomes in Mild-to-Moderate Ulcerative Colitis: A Roundtable Discussion
  • Goals of Therapy for Mild-to-Moderate Ulcerative Colitis: What is Achievable?
  • Overcoming Obstacles in Mild-to-Moderate Ulcerative Colitis: Strategies for Better Adherence and Tolerability of First-Line Therapy
  • Carcinoid Tumors of the Gastrointestinal Tract

    Webcasts/CME archive

     Recent cases - Gastro Other
      Yellow-White Lesions in the Upper Gastrointestinal Tract
      Transient Anti-GAD Antibody Positivity and Acute Pancreatitis with Pancreas Tail Swelling in a Patient with Susceptible Haplotype for Type 1 Diabetes Mellitus
      Pancreatic Injury Successfully Treated with Endoscopic Stenting for Major Pancreatic Duct Disruption
      Jejuno-Jejunal Invagination Caused by Epithelioid Sarcoma: A Case Report
      Gastroparesis Associated with Gastroptosis Presenting as a Lower Abdominal Bulking Mass in a Child: A Case Report

      Cases archive
        




      my personal edition > gastro other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Ketoprofen May Mediate Gastric Dysrhythmias Induced By Chemoembolisation For Liver Tumour

      A DGReview of :"Mediation of transcatheter arterial chemoembolization induced gastric slow-wave dysrhythmia by endogenous prostaglandin"
      Journal of Gastroenterology and Hepatology

      03/26/2002
      By David Loshak


      The prostaglandin synthesis inhibitor ketoprofen may mediate gastric slow-wave dysrhythmias induced by transcatheter arterial chemoembolisation in patients with hepatocellular carcinoma, the most common primary malignant liver tumour.

      However, the improved gastric myoelectrical activity does not stop nausea or vomiting after this chemoembolisation, say specialists in Taichung, Taiwan.

      Noting recent observations of gastric slow-wave dysrhythmias induced by transcatheter arterial chemoembolisation, the specialists speculated that enhanced endogenous prostaglandin might explain the myoelectrical changes. This led them to investigate if ketoprofen might mediate the dysrhythmias.

      Twenty-three patients with hepatocellular carcinoma who had been admitted for transcatheter arterial chemoembolisation were enrolled into this study. A follow-up chemoembolisation was scheduled for two months later.

      During their next admission for chemoembolisation, the patients received 12-hourly intramuscular injections of ketoprofen 50 mg for three days, 48 hours before chemoembolisation, as premedication. Cutaneous electrogastrography was performed before chemoembolisation and within the following 24 hours.

      The change in the fasting cutaneous electrogastrography parameters after chemoembolisation without premedication was not statistically significant. After the procedure, however, the postprandial cutaneous electrogastrography parameters (including the dominant frequency), the percentages of dominant frequency in the normal, bradygastric and tachygastric range, and the dominant frequency instability coefficient, all deteriorated significantly.

      After the follow-up chemoembolisation with ketoprofen premedication, neither the fasting nor the postprandial cutaneous electrogastrography parameters in the control group changed significantly.
      Journal of Gastroenterology and Hepatology 2002; 17(1):46-51. "Mediation of transcatheter arterial chemoembolization induced gastric slow-wave dysrhythmia by endogenous prostaglandin"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send